Ne vada Ove r dose Data to Ac tion Sur ve illanc e Compone nt - PowerPoint PPT Presentation

Ne vada Ove r dose Data to Ac tion Sur ve illanc e Compone nt Re vie w E lyse Mo nro y |Pro g ra m Ma na g e r Sha wn T ho ma s, MPH | Surve illa nc e Co o rdina to r Ne va da Pub lic He a lth T ra ining Ce nte r |UNR, Sc ho o l o f Co mmunity He a lth Sc ie nc e

Pre se nta tion Hig hlig hts  CDC Ove rdo se Da ta to Ac tio n Pro g ra m Ove rvie w  Ne va da Ove rdo se Da ta to Ac tio n Ove rvie w  F unding & Go a ls  Surve illa nc e Co mpo ne nt Stra te g ie s  Drug Ove rdo se Surve illa nc e E pide mio lo g y (DOSE )  Sta te Uninte ntio na l Drug Ove rdo se Re po rting Syste m (SUDORS)  Ra pid Co unt  I nno va tive Surve illa nc e Stra te g ie s  Ope nBe ds  YRBS

CDC OD2A  Building o n Pa st Pro g ra ms “ T o suppo r t r e c ipie nts in ge tting high  E quality, c o mple te , and time lie r data o n nha nc e d Sta te Opio id Ove rdo se Surve illa nc e o pio id pr e sc r ibing and o ve r do se s, and to  E SSE NCE use tho se data to info r m pr e ve ntio n and  SUDORS r e spo nse ”  Pre ve ntio n fo r Sta te s - NCIPC OD2A NOF O  PDMP  Crisis Co o pe ra tive Ag re e me nt  Misc e lla ne o us ‘ One Sho t’ inc lude F AST / MOST da ta Co lle c tio n a nd AB474 Da ta c o lle c tio n T o o ls; a nd Jurisdic tio na l Vulne ra b ility Asse ssme nt

OD2A Prog ra m Compone nts Sur ve illanc e Pr e ve ntion  I nte g ra tio n o f Sta te a nd L o c a l E ffo rts  Mo rb idity  L inka g e s to Ca re & He a lth Syste m Suppo rt  DOSE (E SSE NCE )  Pub lic He a lth a nd Pub lic Sa fe ty  Mo rta lity Co o rdina to r  SUDORS (F o re nsic T o x  E mpo we r Pe o ple to Ma ke Sa fe r Cho ic e s  Ra pid OD De a th Co unt  I nno va tio n  Re a l T ime T re a tme nt Surve illa nc e  YRBS Co mmunity T re nd Ana lysis

Pr oje c t Par tne r s (Sub- r e c ipie nts) Ne vada’s OD2A  Bo a rd o f Pha rma c y Pr ogr am  Wa sho e Co unty He a lth Distric t  Wa sho e Co unty Co ro ne r Me dic a l E xa mine r  So uthe rn Ne va da He a lth Distric t  Cla rk Co unty Co ro ne r  Proje c t Pe riod: Se pte mbe r 1, 2019 – Aug ust 31, 2022  UNR CHS  Ye a r 1 Budg e t Pe riod- Se pt 1,2019-  NyECo mmunity Co a litio n Aug ust 31, 2020  Pa rtne rship Ca rso n City  T ota l Ye a r 1: $4,228,798.00  PACT Co a litio n  PACE Co a litio n  Jo in T o g e the r No rthe rn Ne va da  SE I

Ne va da OD2A Prog ra m Goa ls • Improved decision making, resource allocation, and informed intervention strategies, based on improved quality and dissemination of fatal and non-fatal substance abuse and opioid use data Decision Making “Ac tive Surve illa nc e ” • Enhanced Prescription Drug Monitoring Program (PDMP) that supports evidence-based prescribing, and data sharing to inform prevention and intervention strategies Prescribers Tools I nte g ra tio n & Na rxCa re • Increase the number of individuals referred for substance use/ opioid use/ supportive services from a clinical or community-based setting through health systems, and community- based providers, by streamlining the referral process Linkage to Care Ope nBe ds • Communities have increased capacity to respond to Opioid and Substance Use Disorder and are better equipped to respond to crisis, and support individuals through recovery Local Sub sta nc e a b use spe c ia lists, PH/ PS Capacity Co o rdina tio n • Increased awareness about opioid use, poly drug risk, and increased awareness about OUD stigma, treatment, and recovery Increased Awareness E B Pre ve ntio n Pro g ra mming & Pub lic Me ssa g ing

Sur ve illanc e Str ate gy 1 DOSE Da ta Re po rting a nd Disse mina tio n

DOSE Re porting  Ob je c tive : Co lle c t a nd disse mina te time ly e me rg e nc y de pa rtme nt (E D) da ta o n suspe c te d a ll drug , a ll o pio id, he ro in, a nd a ll stimula nt o ve rdo se s.  Sub sta nc e use re la te d e me rg e nc y de pa rtme nt visits fro m Na tio na l Syndro mic Surve illa nc e Pro g ra m.  Suspe c te d a ll-drug , o pio id, he ro in, a nd stimula nt-re la te d visits  De fine d b y c a se de finitio ns pro vide d b y CDC utilizing c hie f c o mpla int ke ywo rds a nd I CD-10-CM disc ha rg e dia g no sis c o de s.  Re po rte d to CDC b i-we e kly a nd mo nthly.

F ig ure 1. T he re wa s a sig nific a nt de c r e asing tre nd in a ll- drug , opioid, he roin, a nd stimula nt E D visits from July 2019 to De c e mbe r 2019 (ra te s pe r 10,000 E D visits) All Drug, 69.8 59.4 Opioid, 20.4 16.2 Stimulant, 6.2 5.4 Heroin, 4.4 3.7 July 2019 Aug 2019 Sept 2019 Oct 2019 Nov 2019 Dec 2019

F igur e 2. T he r e was a signific ant de c r e asing tr e nd in all- dr ug E D visits in fe male s fr om July 2019 to De c e mbe r 2019 (r ate s pe r 10,000 E D visits) All Drug , 63.5 51.8 Opioid, 14.2 13.4 July 2019 Aug 2019 Sept 2019 Oct 2019 Nov 2019 Dec 2019

F igur e 3. T he r e was a signific ant de c r e asing tr e nd in all- dr ug, opioid, he r oin, and stimulant E D visits in male s fr om July 2019 to De c e mbe r 2019 (r ate s pe r 10,000 E D visits) All Drug, 77.2 68.4 Opioid, 27.6 19.5 Stimulant, 10.5 7.8 Heroin, 7.9 5.4 July 2019 Aug 2019 Sept 2019 Oct 2019 Nov 2019 Dec 2019

F igur e 4. T he r e was a signific ant de c r e asing tr e nd in all- dr ug E D visits in the 0- 14 and 55+ age gr oups fr om July 2019 to De c e mbe r 2019 (r ate s pe r 10,000 E D visits) 15-24 years, 101.0 98.7 25-34 years, 84.2 77.5 35-54 years, 78.5 69.1 55+ years, 54.1 0-14 years, 42.5 41.3 35.2 July 2019 Aug 2019 Sept 2019 Oct 2019 Nov 2019 Dec 2019

Sur ve illanc e Str ate gy 2 SUDORS Da ta Re po rting a nd Disse mina tio n

SUDORS Re porting  Ob je c tive : Co lle c t a nd disse mina te de sc riptio ns o f drug o ve rdo se de a th c irc umsta nc e s using de a th c e rtific a te s a nd ME / C da ta  Ab stra c to rs fro m Wa sho e Co unty C/ ME a nd So uthe rn Ne va da He a lth Distric t re vie w de a ths fo r the c o untie s in the ir jurisdic tio ns a nd a b stra c t the m into NVDRS.  Ca pture s de ta ile d info o n to xic o lo g y, de a th sc e ne inve stig a tio ns, ro ute o f a dministra tio n, a nd o the r risk fa c to rs tha t ma y b e a sso c ia te d with a fa ta l o ve rdo se .  Re po rte d to CDC e ve ry 6 mo nths

SUDORS Ra pid Opioid Ove rdose De te c tion  Ob je c tive : T o mo re ra pidly de te c t o pio id o ve rdo se o utb re a ks o r sha rp inc re a se s in o pio id o ve rdo se de a ths.  Co lla b o ra ting with the Cla rk Co unty Offic e o f the Co ro ne r/ Me dic a l E xa mine r to c o lle c t pre limina ry da ta o n suspe c te d o pio id o ve rdo se s  Da ta c o lle c tio n b e g ins Ma y 1, 2020.

Sur ve illanc e Str ate gy 3 I nno va tive Surve illa nc e I nitia tive s

YRBS T re nd Ana lysis  Wo rking to g e the r with UNR to do 3-ye ar tre nd analysis o f sub stanc e use indic ato rs (2015-2019).  Will o ve rlay the se tre nds with o pio id mo rb idity and mo rtality tre nds.  E me rg e nc y de partme nt visits  Mo rtality data (SUDORS)  PDMP  With o the r Ne vada datase ts  Ne vada Re po rt Card  Juve nile Justic e  Altho ug h c anno t draw dire c t c o mpariso ns b e twe e n the tre nds in YRBS and o the r data so urc e s, this pro je c t aims to sho w the tre nds o f ado le sc e nt risk fac to rs and o pio id mo rb idity and mo rtality data o ve r time .

T re a tme nt Ava ila bility Surve illa nc e - T hroug h Ope nBe ds  Ope nBe ds e le c tro nic b e havio ral he alth re fe rral syste m  Ac ute Care Ho spitals  I n Patie nt Psyc  SAPT A F unde d T re atme nt Pro vide rs  Rural Clinic s  Mo nito ring o f state wide inpatie nt and o utpatie nt tre atme nt availab ility.  Sub stanc e  ASAM L e ve o f Care Ne e de d  Paye rs

T re a tme nt Ava ila bility Surve illa nc e - T hroug h Ope nBe ds  Ne two rk L aunc h thre sho ld: 70%  T arg e t T ime F rame : L ate May

Que stions? E lyse Mo nro y| Pro g ra m Ma na g e r e c mo nro y@ unr.e d u 775-229-5783 Sha wn T ho ma s | Surve illa nc e Co o rdina to r Sha wnT @ me d .unr.e d u 775-470-0496